Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity.

Serum HGF is elevated in obese individuals. This study examined the contribution of excess adipose tissue to increased circulating HGF levels in obesity. Serum HGF was measured by ELISA before and after weight loss due to bariatric surgery or a 24-h fast. At 6.1 +/- 0.1 mo following surgery, BMI (50.6 +/- 1.6 vs. 35.1 +/- 1.3 kg/m(2); P < 0.0001) and serum HGF were significantly decreased (1,164 +/- 116 vs. 529 +/- 39 pg/ml, P < 0.001). A 24-h fast did not change serum HGF, but serum leptin was significantly reduced (67.7 +/- 7.1 vs. 50.3 +/- 8.3 ng/ml, P = 0.02). HGF secretion in vitro from adipocytes of obese (BMI 40.3 +/- 2.8 kg/m(2)) subjects was significantly greater (80.9 +/- 10.4 vs. 21.5 +/- 4.0 pg/10(5) cells, P = 0.008) than release from adipocytes of lean (BMI 23.3 +/- 1.4 kg/m(2)) subjects. HGF mRNA levels determined by real-time RT-PCR were not different in adipocytes from lean (BMI 24.0 +/- 0.8 kg/m(2)) and obese (45.7 +/- 3.0 kg/m(2)) subjects, but serum HGF was significantly elevated in the obese individuals studied (787 +/- 61 vs. 489 +/- 49 pg/ml, P = 0.001). TNF-alpha (24 h treatment) significantly increased HGF release from subcutaneous adipocytes 23.6 +/- 8.3% over control (P = 0.02). These data suggest that elevated serum HGF in obesity is in part attributable to excess adipose tissue and that this effect can be reversed by reducing adipose tissue mass through weight loss. Increased HGF secretion from adipocytes of obese subjects may be due to posttranscriptional events possibly related to adipocyte size and stimulation by elevated TNF-alpha in the adipose tissue of obese individuals.

[1]  P. Sucharda,et al.  Angiogenic factors are elevated in overweight and obese individuals , 2005, International Journal of Obesity.

[2]  P. De Groote,et al.  Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization. , 2005, European heart journal.

[3]  J. Świerczyński,et al.  Serum Hepatocyte Growth Factor Concentration in Obese Women Decreases after Vertical Banded Gastroplasty , 2005, Obesity surgery.

[4]  H. Hauner.  Secretory factors from human adipose tissue and their functional role , 2005, Proceedings of the Nutrition Society.

[5]  T. Imaizumi,et al.  Strong association between serum hepatocyte growth factor and metabolic syndrome. , 2005, The Journal of clinical endocrinology and metabolism.

[6]  C. Lelliott,et al.  Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. , 2005, Obesity research.

[7]  P. Scherer,et al.  Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome , 2005, Journal of internal medicine.

[8]  星本 さおり.  Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects , 2005 .

[9]  I. S. Wood,et al.  Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.

[10]  C. Kahn,et al.  Role of Insulin Action and Cell Size on Protein Expression Patterns in Adipocytes* , 2004, Journal of Biological Chemistry.

[11]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[12]  Keith L. March,et al.  Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.

[13]  R. L. Richardson,et al.  Adipose tissue angiogenesis. , 2004, Journal of animal science.

[14]  P. Havel.  Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. , 2004, Diabetes.

[15]  A. Hamsten,et al.  Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy , 2003, AIDS.

[16]  R. Considine,et al.  Obesity is associated with increased levels of circulating hepatocyte growth factor. , 2003, Journal of the American College of Cardiology.

[17]  P. Arner.  The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones , 2003, Trends in Endocrinology & Metabolism.

[18]  J. Fallon,et al.  Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques. , 2002, Atherosclerosis.

[19]  M. Aoki,et al.  Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease. , 2002, Endocrine journal.

[20]  K. Kohara,et al.  Association between carotid arterial remodeling and plasma concentration of circulating hepatocyte growth factor , 2001, Journal of hypertension.

[21]  L. Naldini,et al.  Hepatocyte Growth Factor Is a Regulator of Monocyte-Macrophage Function1 , 2001, The Journal of Immunology.

[22]  P. Kern,et al.  The Translational Regulation of Lipoprotein Lipase in Diabetic Rats Involves the 3′-Untranslated Region of the Lipoprotein Lipase mRNA* , 2000, The Journal of Biological Chemistry.

[23]  C. Zoccali,et al.  Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  R. Considine,et al.  Tumor necrosis factor-alpha inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans. , 2000, The Journal of clinical endocrinology and metabolism.

[25]  T. Ogihara,et al.  Hepatocyte growth factor (HGF) as a potential index of severity of hypertension. , 1999, Hypertension research : official journal of the Japanese Society of Hypertension.

[26]  Y. Matsumoto,et al.  Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease. , 1999, The Journal of clinical endocrinology and metabolism.

[27]  M. Nishimura,et al.  Increased serum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. , 1998, The Journal of clinical endocrinology and metabolism.

[28]  R. Zarnegar,et al.  A novel transcriptional regulatory region within the core promoter of the hepatocyte growth factor gene is responsible for its inducibility by cytokines via the C/EBP family of transcription factors , 1997, Molecular and cellular biology.

[29]  F. Lönnqvist,et al.  Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. , 1997, The Journal of clinical investigation.

[30]  R. Considine,et al.  Responses of Leptin to Short-Term Fasting and Refeeding in Humans: A Link With Ketogenesis but Not Ketones Themselves , 1996, Diabetes.

[31]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[32]  B. Elliott,et al.  Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. , 1996, The American journal of pathology.

[33]  H. Kawasaki,et al.  Serum hepatocyte growth factor levels in liver diseases: Clinical implications , 1995, Hepatology.

[34]  T. Nakamura,et al.  Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. , 1994, DNA and cell biology.

[35]  R. Considine,et al.  A new technique for biopsy of human abdominal fat under local anaesthesia with Lidocaine. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.